Bahn R S, Dutton C M, Natt N, Joba W, Spitzweg C, Heufelder A E
Division of Endocrinology, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA.
J Clin Endocrinol Metab. 1998 Mar;83(3):998-1002. doi: 10.1210/jcem.83.3.4676.
It is acknowledged that the TSH receptor (TSHr) on thyroid follicular cells is the autoantigen involved in the hyperthyroidism of Graves' disease. However, whether this receptor is expressed in extrathyroidal tissues, and whether it participates directly in the pathogenesis of Graves' ophthalmopathy (GO) are unclear. We sought to detect the expression of TSHr messenger ribonucleic acid (mRNA) and protein in orbital adipose/connective tissue specimens and in human orbital preadipocyte fibroblast cultures using liquid hybridization analysis and immunohistochemical methods. We demonstrated intact and variant TSHr mRNA transcripts and TSHr-like immunoreactivity in orbital adipose/connective tissue specimens from patients with GO. In addition, TSHr-like immunoreactivity was detected in early passage GO preadipocyte fibroblast cultures that were shown to include some adipose cells. In contrast, neither TSHr mRNA nor protein was detected in normal orbital adipose/connective tissue specimens or in late passage GO orbital fibroblast cultures containing no lipid-laden adipose cells. In conclusion, we showed that TSHr is expressed in the adipose/connective tissue of the diseased orbit in GO. In addition, TSHr is demonstrable in early passage GO preadipocyte orbital fibroblast cultures that contain a subpopulation of adipocytes. Subsequent passaging of these cells results in the loss of both TSHr expression and adipocyte-specific staining. These results suggest that both the expression of this receptor and the accumulation of adipose tissue in the orbit in GO may be induced in vivo by a humoral factor(s) not present in the cell culture environment.
甲状腺滤泡细胞上的促甲状腺激素受体(TSHr)被认为是Graves病甲亢所涉及的自身抗原。然而,该受体是否在甲状腺外组织中表达,以及它是否直接参与Graves眼病(GO)的发病机制尚不清楚。我们试图使用液相杂交分析和免疫组化方法检测眼眶脂肪/结缔组织标本以及人眼眶前脂肪细胞成纤维细胞培养物中TSHr信使核糖核酸(mRNA)和蛋白质的表达。我们在GO患者的眼眶脂肪/结缔组织标本中证实了完整和变异的TSHr mRNA转录本以及TSHr样免疫反应性。此外,在早期传代的GO前脂肪细胞成纤维细胞培养物中检测到TSHr样免疫反应性,这些培养物显示含有一些脂肪细胞。相比之下,在正常眼眶脂肪/结缔组织标本或不含脂质负载脂肪细胞的晚期传代GO眼眶成纤维细胞培养物中均未检测到TSHr mRNA或蛋白质。总之,我们表明TSHr在GO患病眼眶的脂肪/结缔组织中表达。此外,在含有脂肪细胞亚群的早期传代GO前脂肪细胞眼眶成纤维细胞培养物中可检测到TSHr。这些细胞的后续传代导致TSHr表达和脂肪细胞特异性染色均丧失。这些结果表明,GO眼眶中该受体的表达和脂肪组织的积累可能在体内由细胞培养环境中不存在的体液因子诱导。